Assessment of pancreatic characteristics using spectral CT imaging
Assessment of Pancreatic Physiological and Pathological Characteristics Based on Spectral CT Feature Parameters: A Related Study
This study is testing a new type of CT scan to see if it can help doctors better understand pancreatic diseases by looking at how the pancreas works and what might be wrong with it.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1500 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Shengjing Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Shenyang, Liaoning) |
| Trial ID | NCT06510036 on ClinicalTrials.gov |
What this trial studies
This observational study involves patients who have undergone CT scans of the pancreas at Shengjing Hospital starting in January 2024. It collects and analyzes spectral CT data to evaluate both physiological and pathological characteristics of pancreatic tissue. The study utilizes dual-energy CT technology to quantify parameters such as iodine uptake and extracellular volume, aiming to develop models that correlate these findings with traditional CT data and patient health status. The goal is to enhance the understanding of pancreatic diseases and improve diagnostic accuracy.
Who should consider this trial
Good fit: Ideal candidates are patients who have undergone CT scans involving the pancreas at the hospital since March 2024.
Not a fit: Patients with previous pancreatic surgery, severe systemic diseases, or excessive pancreatic atrophy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic techniques for pancreatic diseases, allowing for earlier and more accurate detection.
How similar studies have performed: Other studies utilizing dual-energy CT have shown promise in improving diagnostic capabilities, suggesting this approach may be beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1.Since March 2024, I have been visiting our hospital for various reasons and have undergone CT scans involving the pancreas (using energy spectrum CT) Exclusion Criteria: 1. Previous pancreatic surgery with incomplete pancreatic tissue. 2. Severe systemic diseases that result in severe organ dysfunction 3. Excessive pancreatic atrophy or other reasons cannot accurately delineate ROI
Where this trial is running
Shenyang, Liaoning
- Shengjing Hospital of China Medical University — Shenyang, Liaoning, China (Recruiting)
Study contacts
- Study coordinator: Yu Shi, doctor
- Email: 18940259980@163.com
- Phone: 18940259980
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.